Introduction
Implantable cardioverter-defibrillators (ICDs) are routinely used for primary and secondary prevention of arrhythmiarelated deaths in patients with heart failure and reduced left ventricular ejection fraction. [1] [2] [3] Complications that occur during transvenous ICD implantation have been well described in the literature and include early complications such as pocket hematoma, pocket or lead infection, lead dislodgment, myocardial perforation, postoperative arrhythmia, and pericardial effusion with or without tamponade. 3, 4 Late complications include lead fracture and pocket or lead infection, but rarely lead dislodgment. This case report describes an unusual case of late superior vena cava (SVC) coil dislodgment.
Case report
A 48-year-old man with a nonischemic cardiomyopathy underwent ICD implant at an outside institution for primary prevention of sudden cardiac death. The ICD was a Biotronik Inventra 7 VR-T DX with a single-coil VDD ICD lead. The maximum output of this device is 45 J. Defibrillation threshold (DFT) testing at implant showed the following results during 3 separate ventricular fibrillation (VF) inductions: failed 35 J, failed 40 J, failed 40 J with reversed polarity. In each case the patient was rescued with an external defibrillator. Because of the high DFT, implanting physicians chose to add an additional SVC coil, which was placed in the innominate vein. After the coil was added, successful defibrillation was achieved with 35 J reversed polarity. A postimplant chest radiograph is shown in Figure 1 . In the operative report from the outside institution, there was no mention of a requirement to reposition the SVC coil proximally to achieve adequate DFT.
The patient was discharged on the following day and had an uneventful postoperative course. Approximately 1 year after the ICD implant, the patient had a routine chest radiograph at our institution that showed stable position of the ICD leads ( Figure 2 ). He continued to be treated for his heart failure with the addition of intravenous (IV) milrinone.
Six months later (18 months after the initial implant) the patient presented to our institution with another exacerbation of his congestive heart failure. A chest radiograph from the emergency room is shown in Figure 3 .
The patient had never required any ICD shocks to treat ventricular arrhythmias. He had no complaints other than shortness of breath and exercise intolerance. Specifically, there were no complaints in his left neck.
On physical examination his blood pressure was 135/86, pulse 96 beats/min. The patient had 21 jugular vein distention bilaterally, bibasilar crackles, and 21 pedal edema bilaterally. Heart sounds were regular, tachycardic, and distant. There were no visible abnormalities of the left neck other than jugular vein distention, but with deep palpation, the SVC coil lead could be felt under the subcutaneous tissues in the region of the left internal jugular vein. There was no decreased range of motion of the neck, or any pain with neck movement. The site of the ICD can in the left pectoral region was well healed.
Because the displaced SVC coil lead was not causing any symptoms for the patient, we elected to attempt DFT testing with the SVC coil OFF, using the right ventricular (RV) coil and can alone to potentially avoid a surgical procedure. Although that configuration had failed in the past, we thought it worth trying again after the prolonged therapy with IV milrinone, and after several days of diuresis in the hospital. We performed the DFT testing in the operating room on the fourth hospital day, so that in the event the DFT was not adequate, we could immediately move to reposition or replace the SVC coil.
The patient was placed on the operating table with R2 pads in optimal anteroposterior position. After the patient was sedated by anesthesia, VF was induced with a T-wave synchronized shock. VF was appropriately sensed and was successfully defibrillated to sinus rhythm with a 38 J biphasic shock reversed polarity. The shock impedance was 51 ohms. We elected to leave the ICD programmed with the SVC coil OFF and leave the electrically abandoned SVC coil in the dislodged location to avoid a surgical procedure with its risks of infection and bleeding. Final device programming was first shock at 38 J and all subsequent shocks at max output of 45 J. The pacemaker was programmed VVI lower rate at 40 beats/min to avoid RV pacing.
Discussion
This is an unusual case of an SVC coil that dislodged from the innominate vein into the left internal jugular vein over a year after initial device implant, caused no symptoms, and was discovered only incidentally. As shown, the SVC coil was left quite proximally at initial implant; this case report can serve to caution implanters to position these coils more distally to avoid this rare complication.
Studies have reported the incidence of implanted lead dislodgment to be between 2% and 20.7%. [5] [6] [7] [8] In 1995, 1 series described dislodgment of SVC coils migrating distally, with the SVC coils ending up in the right atrium despite being "adequately" sutured in the pectoral region. Both of those cases occurred approximately 3 months after implant and required reoperation to achieve adequate DFTs. 7 In a study of the incidence of venous obstruction after ICD implant, it was noted that patients with a dual-coil ICD lead had an increased incidence of venous obstruction, at 44%, over those with an RV coil ICD lead and a separate SVC coil lead, at 17%. 9 Other studies have reported on dislodgments of leads other than the SVC coil. Lee and colleagues 8 conducted a
KEY TEACHING POINTS
When implantable cardioverter-defibrillator (ICD) system parameters are out of range, or failure to defibrillate is seen, search for ICD system reprogramming options before jumping to reoperation.
Look carefully at all diagnostic testing obtained in patients with implanted devices, even when the indication for the diagnostic study had nothing to do with the device.
Implant superior vena cava (SVC) coils somewhat distally, leaving part of the coil in the SVC to avoid proximal dislodgment. prospective multicenter study evaluating early complications post ICD implantation in total of 3340 patients; 57 (1.7%) patients had lead dislodgements. Ghani and colleagues 10 reported a 4.4% (86/3903) incidence of reoperation for lead revision that was more common in younger and male patients; right atrial and ICD leads had the highest risk of dislodgment. Takahashi and colleagues 6 conducted a study comparing lead dislodgment in single-chamber vs dualchamber ICDs in 178 consecutive patients. Of the 178 patients, 5 (3%) were found to have lead dislodgments. One occurred in the RV lead of the single-chamber ICD group, and the other 4 were atrial lead dislodgments in the dual-chamber ICD group; mean time to lead dislodgment was 6 6 5 months.
There is currently controversy about doing DFT testing during initial ICD implantation. The risks of performing DFT testing include inability to terminate ventricular tachycardia/VF, systemic shock leading to cardiac arrest, risk of hypoperfusion to the vital organs, stroke, and death. 11 Other factors that can impact DFT testing thresholds include procedural complications such as pneumothorax, medications such as amiodarone and anesthetic medicines that are administered during the implant procedure, 12 shock waveform (monophasic vs biphasic), 13 and cardiac mass. Patients with decreased left ventricular function have the highest risk of developing pump failure. One Canadian study showed that in over 19,000 ICD implants, the incidence of DFT testing-related death was 0.016%, DFT testing-related stroke was 0.026%, and DFT testing-related prolonged resuscitation was 0.14%.
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The recently published NORDIC 14 (1077 patients) and SIMPLE 15 trials (2500 patients) showed noninferiority of eliminating DFT testing for initial ICD implants in longterm follow-up. The studies showed that DFT testing is generally well tolerated but does not improve clinical shock efficacy or reduce arrhythmic death. However, the benefits of performing DFT testing include assessing the integrity of the entire system and detecting high DFTs that may require surgical modification. Each individual case should be assessed to determine the risks and possible benefits of DFT testing to determine if DFT should be performed. In the case presented here, we felt it prudent to assess the DFT because of the prior history of inadequate DFT and possible need for SVC coil repositioning. We were able to eliminate or "turn off" the SVC coil from the DFT circuit, and achieve an adequate DFT. We hypothesize that after therapy with IV milrinone for a period of time, the heart improved somewhat to achieve a lower DFT than was measured at initial implant.
Conclusion
In the present case report, we describe a rare proximal migration of an SVC coil into the internal jugular vein that occurred more than a year after the initial implant, was discovered fortuitously, caused no symptoms, and was successfully managed with reprogramming of the device to exclude SVC coil.
